We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clues for Drugging the "Undruggable"

News   Nov 05, 2018 | Original story from the Friedrich Miescher Institute for Biomedical Research

 
Clues for Drugging the "Undruggable"

Thalidomide analogs recruit zinc finger domains of transcription factors to the CRL4-CRBN ubiquitin ligase and lead to degradation. Credit: Friedrich Miescher Institute for Biomedical Research

 
 
Advertisement
 

RELATED ARTICLES

New Technique Enables Continuous Monitoring of Proteins

News

Researchers have developed an antibody as a biosensor, to continuously monitor rapid changes in the concentration of EGFR, a protein present on cancer cells and in body fluids.

READ MORE

Scientists Get a Close-Up of the Ribosomal RNA Production Line

News

Researchers used cryo-electron microscopy (cryo-EM) to capture the structures of RNA polymerase while in complex with DNA and showed how its activity is changed in response to poor-growth conditions.

READ MORE

Team Investigates Potential Drug Therapy Combination for Lung Cancer

News

Researchers report that in non-small-cell lung carcinoma, secondary mutations occurring with another gene alteration known as ALK make the efficacy of alectinib, an otherwise commonly used drug for treating lung cancer, become unfavorable. Combining alectinib with another drug could help to overcome these effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE